A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertensionMUBARAK, Kamal K.Respiratory medicine. 2010, Vol 104, Num 1, pp 9-21, issn 0954-6111, 13 p.Article

Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertensionTONELLI, Adriano R; ALNUAIMAT, Hassan; MUBARAK, Kamal et al.Respiratory medicine. 2010, Vol 104, Num 4, pp 481-496, issn 0954-6111, 16 p.Article

Effect of Balloon Inflation Volume on Pulmonary Artery Occlusion Pressure in Patients With and Without Pulmonary HypertensionTONELLI, Adriano R; MUBARAK, Kamal K; NING LI et al.Chest (American College of Chest Physicians). 2011, Vol 139, Num 1, pp 115-121, issn 0012-3692, 7 p.Article

Cyclophosphamide versus placebo in scleroderma lung diseaseTASHKIN, Donald P; ELASHOFF, Robert; SEIBOLD, James R et al.The New England journal of medicine. 2006, Vol 354, Num 25, pp 2655-2666, issn 0028-4793, 12 p.Article

Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis results from the scleroderma lung studyKHANNA, Dinesh; CLEMENTS, Philip J; VARGA, John et al.Arthritis and rheumatism. 2005, Vol 52, Num 2, pp 592-600, issn 0004-3591, 9 p.Article

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung diseaseTASHKIN, Donald P; ELASHOFF, Robert; SEIBOLD, James R et al.American journal of respiratory and critical care medicine. 2007, Vol 176, Num 10, pp 1026-1034, issn 1073-449X, 9 p.Article

Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease : Results from the scleroderma lung studyKHANNA, Dinesh; XIAOHONG YAN; RILEY, David J et al.Arthritis and rheumatism. 2007, Vol 56, Num 5, pp 1676-1684, issn 0004-3591, 9 p.Article

Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-β1 in vitroNASREEN, Najmunnisa; MOHAMMED, Kamal A; MUBARAK, Kamal K et al.American journal of physiology. Lung cellular and molecular physiology. 2009, Vol 41, Num 1, issn 1040-0605, L115-L124Article

Hypoxia-induced endothelial CX3CL1 triggers lung smooth muscle cell phenotypic switching and proliferative expansionJIANLIANG ZHANG; HANBO HU; PALMA, Nadia L et al.American journal of physiology. Lung cellular and molecular physiology. 2012, Vol 47, Num 5, issn 1040-0605, L912-L922Article

Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studiesBARST, Robyn J; MUBARAK, Kamal K; GLADWIN, Mark T et al.British journal of haematology. 2010, Vol 149, Num 3, pp 426-435, issn 0007-1048, 10 p.Article

Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental ModelsSHENOY, Vinayak; GJYMISHKA, Altin; AGARWAL, Deepmala et al.American journal of respiratory and critical care medicine. 2013, Vol 187, Num 6, pp 648-657, issn 1073-449X, 10 p.Article

An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell DiseaseKLINGS, Elizabeth S; MACHADO, Roberto F; ROSENZWEIG, Erika B et al.American journal of respiratory and critical care medicine. 2014, Vol 189, Num 6, pp 727-740, issn 1073-449X, 14 p.Article